Cargando…
Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report
BACKGROUND: Controlling retinoblastoma with seeding is challenging despite advances in treatment modalities. Intravitreal melphalan is an alternative to external beam radiation or enucleation for recurrent or refractory vitreous seeds. Significant ocular side effects following intravitreal melphalan...
Autores principales: | Chao, An- Ning, Kao, Ling-Yuh, Liu, Laura, Wang, Nan-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791807/ https://www.ncbi.nlm.nih.gov/pubmed/26975871 http://dx.doi.org/10.1186/s12886-016-0204-6 |
Ejemplares similares
-
Toxicity to intravitreal melphalan in a patient with retinoblastoma
por: Solaz-Ruiz, Marta Gema, et al.
Publicado: (2023) -
Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
por: Shah, Nisha V., et al.
Publicado: (2014) -
Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2020) -
Intravitreal melphalan for persistent retinoblastoma vitreous seeds
por: Redondo-Villanueva, Marie Jeazelle H., et al.
Publicado: (2022) -
Histopathologic findings after selective ophthalmic arterial injection of melphalan for retinoblastoma
por: Chen, Ho-Min, et al.
Publicado: (2019)